Iktos: Funding, Investors & Team (Sep 2026)
Founded in October 2016, Iktos is a new company that specializes in developing artificial intelligence solutions for chemical research in areas such as medicinal chemistry and new drug design. Utilizing deep learning generative models, Iktos has created an innovative technology that allows for the optimization of molecules using existing data. This technology streamlines the drug discovery process by improving productivity in pharmaceutical R&D. Iktos offers both professional services and a SaaS software platform, including their Makya™ platform which enables multi-parametric optimization of lead compounds based on target candidate profiles, and their Spaya™ synthesis planning software which is based on proprietary AI technology for retrosynthesis.
Iktos has raised $16.4M across 1 funding round on record, the most recent a Series A of $16.4M announced in Mar 2023.
That round is above the $5.7M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Iktos Company Profile and Key Stats
Latest funding round on record: Mar 2023.
Iktos Funding Rounds
Iktos Founders and Leadership Team
Contact details for the Iktos team: 1 of 1 has an email address on file.
Start 14-day free trial →Iktos Funding Compared to Other Artificial Intelligence Startups
Iktos' latest round of $16.4M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Iktos in Artificial Intelligence and Paris
Companies Similar to Iktos
Huscarl provides AI-native actuarial advisory and insurance analytics for corporate risk managers and finance…
Macrodata Labs is a technology company that provides data infrastructure for the artificial intelligence and…
Haiku is revolutionizing legal practice by placing artificial intelligence and data at the service of law.…
NotiPark is a fully automated detection and payment solution for parking spaces on public roads using…
Comand AI equips defense forces with unmatched abilities in decision-making and operations.
Reshaping the way businesses understand and leverage creator content —faster, safer, and more effective than…
Rocapine AI-native venture studio focused on developing mobile apps within the digital health and self-care…
Prophesee is the inventor of the world’s most advanced neuromorphic vision systems. Prophesee’s patented…
Kyber is an AI platform that enables teams to build and deploy AI agents that automate workflows across tools…
Alta Ares is a data integration surveillance service provider that utilizes drone imaging.
NP Company is an AI-based software simulation startup that focuses on providing realistic physics simulations.
Dust is a company offering an AI platform that allows businesses to create and implement personalized virtual…
Iktos Funding FAQs
What does Iktos do?
Founded in October 2016, Iktos is a new company that specializes in developing artificial intelligence solutions for chemical research in areas such as medicinal chemistry and new drug design. Utilizing deep learning generative models, Iktos has created an innovative technology that allows for the optimization of molecules using existing data. This technology streamlines the drug discovery process by improving productivity in pharmaceutical R&D. Iktos offers both professional services and a SaaS software platform, including their Makya™ platform which enables multi-parametric optimization of lead compounds based on target candidate profiles, and their Spaya™ synthesis planning software which is based on proprietary AI technology for retrosynthesis.
How much funding has Iktos raised?
Iktos has raised $16.4M across 1 round on record. The most recent is a Series A of $16.4M announced in Mar 2023.
When did Iktos last raise funding?
Iktos' most recent funding round on record is a Series A of $16.4M, announced in Mar 2023.
Who founded Iktos?
FundedIQ lists Quentin Perron (Founder) at Iktos.
Where is Iktos headquartered?
Iktos is based in Paris, Ile-De-France, France.
How many employees does Iktos have?
Iktos is in the 51-100 employee band.
How does Iktos' funding compare to other Artificial Intelligence startups?
Iktos' latest round of $16.4M is above the $5.7M median round size for Artificial Intelligence companies on FundedIQ across 7,234 tracked companies over the last two years.
About FundedIQ's Iktos Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Iktos is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.